KUPFFER BIOTHECH - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 64,300 | 195,600 | 187,100 | 150,000 | 257,336 | 127,045 | 208,046 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -77,769 | -108,876 | -2,580 | -1,716 | -8,977 | 62,653 | -57,177 | 9,298 |
| Equity | -247,964 | -356,840 | -359,420 | -361,136 | -370,113 | -307,459 | -364,636 | -355,338 |
| Liabilities | 278,800 | 383,935 | 392,792 | 392,154 | 410,561 | 427,108 | 433,572 | 442,064 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 30,836 | 27,095 | 33,372 | 31,018 | 40,448 | 119,649 | 68,936 | 8,724 |
| Total assets | 30,836 | 27,095 | 33,372 | 31,018 | 40,448 | 119,649 | 68,936 | 8,724 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 985 | 892 | 5,491 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +204.2% | -4.3% | -19.8% | +71.6% | -50.6% | +63.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -252.2% | -401.8% | -7.7% | -5.5% | -22.2% | 52.4% | -82.9% | 106.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -169.3% | -1.3% | -0.9% | -6.0% | 24.3% | -45.0% | 4.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 35,073 | 97,800 | 160,367 | 150,000 | 257,336 | 127,045 | 208,046 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
KUPFFER BIOTHECH - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-23 | 2026-07-26 | 0.21 |
| 2026-05-03 | 2026-05-06 | 0.31 |
| 2026-04-27 | 2026-04-29 | 0.31 |
| 2026-04-24 | 2026-04-26 | 82.56 |
| 2026-04-20 | 2026-04-23 | 82.25 |
| 2026-03-27 | 2026-03-27 | 82.21 |
| 2026-03-17 | 2026-03-25 | 82.21 |
| 2026-02-18 | 2026-02-19 | 82.31 |
| 2026-01-22 | 2026-02-17 | 0.06 |
| 2026-01-16 | 2026-01-18 | 49.35 |
| 2025-12-16 | 2025-12-17 | 82.25 |
| 2025-06-17 | 2025-06-26 | 162.92 |
| 2025-06-11 | 2025-06-16 | 80.67 |
| 2025-06-08 | 2025-06-09 | 80.67 |
| 2025-05-16 | 2025-06-04 | 80.67 |
| 2023-06-16 | 2023-06-25 | 83.19 |
| 2023-05-02 | 2023-06-15 | 0.94 |
| 2023-04-26 | 2023-04-28 | 0.94 |
| 2023-03-16 | 2023-04-02 | 82.25 |
| 2023-02-17 | 2023-02-20 | 82.62 |
| 2023-02-06 | 2023-02-16 | 0.37 |
| 2023-01-24 | 2023-02-03 | 0.37 |
| 2023-01-17 | 2023-01-22 | 164.83 |
| 2022-12-16 | 2023-01-16 | 82.58 |
| 2022-11-21 | 2022-12-15 | 0.33 |
| 2022-11-17 | 2022-11-18 | 0.33 |
| 2022-10-28 | 2022-11-09 | 0.33 |
| 2022-08-23 | 2022-08-30 | 81.70 |
KUPFFER BIOTHECH - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-04-01 | 2026-04-02 | 6.06 |
| 2026-03-29 | 2026-03-31 | 3881.44 |
| 2025-10-30 | 2025-11-25 | 0.44 |
| 2025-09-30 | 2025-10-16 | 0.44 |
| 2025-09-19 | 2025-09-29 | 0.42 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
KUPFFER BIOTHECH, UAB (code 304038108) is a Private Limited Liability Company engaged in leasing of intellectual property and similar products, except copyrighted works. In 2025, the company generated revenue of €208.0K and returned to a small net profit of €9.3K, after a loss of €57.2K in 2024. Profitability improved materially from the previous year, with the 2025 profit margin at 4.5%, compared with a negative margin in 2024 and 24.3% profit margin in 2023. Revenue increased by 63.8% year on year in 2025, although it remained below the 2023 level, so the two-year revenue trend is still negative at -19.1%. The balance sheet remained highly leveraged, with liabilities of €442.1K against negative equity of €355.3K and total assets of only €8.7K. The very small asset base makes leverage and return ratios difficult to interpret in a conventional way, and asset turnover appears exceptionally high because of the limited assets on hand. Revenue per employee was €208.0K and profit per employee was €9.3K in 2025.